Daniel Pascal Mujuni

Dr. Daniel Pascal Mujuni

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NKNORMAN JONAS KYALA
NORMAN JONAS KYALA
IMInnocent B. Mboya
Innocent B. Mboya
ESElichilia Shao
Elichilia Shao
FSFrancis Sakita
Francis Sakita
KKKajiru Gadiel Kilonzo
Kajiru Gadiel Kilonzo
FLFuraha Lyamuya
Furaha Lyamuya
Background: COVID-19 caused a profound global impact, resulting in significant cases and deaths. The progression of COVID-19 clinical manifestations is influenced by a dysregulated inflammatory response. Early identification of the subclinical progression is crucial for timely intervention and improved patient outcomes. While there are various biomarkers to predict disease severity and outcomes, their accessibility and affordability pose challenges in resource-limited settings. We explored the potentiality of the neutrophil-to-lymphocyte ratio (NLR) as a cost-effective inflammatory marker to predict disease severity, clinical deterioration, and mortality in affected patients. Methodology: A hospital-based retrospective cohort study was conducted at KCMC Hospital among COVID-19 patients followed from admission to discharge between 1st March 2020 and 31st March 2022. NLR was calculated as the absolute neutrophil count in μL divided by the absolute lymphocyte count in μL. The NLR cut-off value was determined using Receiver Operating Characteristic (ROC) analysis and assessed its predictive ability at admission for in-hospital mortality. The Chi-square test compared the proportion of NLR by patient characteristics. The association of NLR with disease severity and mortality was analyzed using the modified Poisson and Cox regression models, respectively. Results: The study included 504 patients, with a median age of 64 years, 57.1% were males, and 68.3% had severe COVID-19. The in-hospital COVID-19 mortality rate was 37.7%. An NLR cutoff value of 6.1 or higher had a sensitivity of 92.1% (95% CI 89.2%–94.0%) and a specificity of 92.0% (95% CI 89.7%–94.4%). Additionally, 39.5% of patients with an NLR value of 6.1 or higher had increased risk of severe disease, subsequent clinical deterioration, and mortality. Conclusion and recommendation: An NLR value of 6.1 or higher at the time of hospital admission associated with severe disease, clinical deterioration, and mortality in patients with COVID-19. Integration of NLR as a prognostic parameter in COVID-19 prognosis scales could improve risk assessment and guide appropriate management strategies for COVID-19 patients, as well as for potential future viral-related pneumonias. Further prospective studies are necessary to validate these findings and evaluate the clinical utility of NLR in larger cohorts of patients.

29 February 2024 in medRxiv
Verified
Preprint
Open access
PDF file
NKNORMAN JONAS KYALA
NORMAN JONAS KYALA
IMInnocent B. Mboya
Innocent B. Mboya
ESElichilia Robert Shao
Elichilia Robert Shao
FSFrancis M. Sakita
Francis M. Sakita
KKKajiru Gadiel Kilonzo
Kajiru Gadiel Kilonzo
FLFuraha Lyamuya
Furaha Lyamuya
Background: COVID-19 caused a profound global impact, resulting in significant cases and deaths. The progression of COVID-19 clinical manifestations is influenced by a dysregulated inflammatory response. Early identification of the subclinical progression is crucial for timely intervention and improved patient outcomes. While there are various biomarkers to predict disease severity and outcomes, their accessibility and affordability pose challenges in resource-limited settings. We explored the potentiality of the neutrophil-to-lymphocyte ratio (NLR) as a cost-effective inflammatory marker to predict disease severity, clinical deterioration, and mortality in affected patients. Methodology: A hospital-based retrospective cohort study was conducted at KCMC Hospital among COVID-19 patients followed from admission to discharge between 1 st March 2020 and 31 st March 2022. NLR was calculated as the absolute neutrophil count in µL divided by the absolute lymphocyte count in µL. The NLR cut-off value was determined using Receiver Operating Characteristic (ROC) analysis and assessed its predictive ability at admission for in-hospital mortality. The Chi-square test compared the proportion of NLR by patient characteristics. The association of NLR with disease severity and mortality was analyzed using the modified Poisson and Cox regression models, respectively. Results: The study included 504 patients, with a median age of 64 years, 57.1% were males, and 68.3% had severe COVID-19. The in-hospital COVID-19 mortality rate was 37.7%. An NLR cutoff value of 6.1 or higher had a sensitivity of 92.1% (95% CI 89.2%–94.0%) and a specificity of 92.0% (95% CI 89.7%–94.4%). Additionally, 39.5% of patients with an NLR value of 6.1 or higher had increased risk of severe disease, subsequent clinical deterioration, and mortality. Conclusion and recommendation: An NLR value of 6.1 or higher at the time of hospital admission associated with severe disease, clinical deterioration, and mortality in patients with COVID-19. Integration of NLR as a prognostic parameter in COVID-19 prognosis scales could improve risk assessment and guide appropriate management strategies for COVID-19 patients, as well as for potential future viral-related pneumonias. Further prospective studies are necessary to validate these findings and evaluate the clinical utility of NLR in larger cohorts of patients.

2 January 2026 in Clinical Case Reports
Verified
Journal Article
Open access
DMDaniel Pascal Mujuni
Daniel Pascal Mujuni
ASAbid Sadiq
Abid Sadiq
KKKajiru G. Kilonzo
Kajiru G. Kilonzo
RHRaya S. Hamad
Raya S. Hamad
AMAbel Mwanga
Abel Mwanga
NCNyasatu G. Chamba
Nyasatu G. Chamba
Emphysematous pyelonephritis is a rare, life‐threatening infection of the kidney characterized by necrosis and gas formation within the renal parenchyma, collecting system, and perinephric tissue. It commonly occurs in patients with poorly controlled type 2 diabetes mellitus (T2DM) and in those with obstructive nephropathy. The most frequent causative pathogen is Escherichia coli , while Candida albicans is rarely implicated. This condition carries a high fatality rate, and early, aggressive medical interventions are recommended. We report a 66‐year‐old female with uncontrolled T2DM who presented with constitutional symptoms and abdominal pain, clinically suggestive of diabetic ketoacidosis with urinary tract infection (UTI). Urine culture revealed Candida albicans , and abdominal computed tomography (CT) revealed gas within the renal parenchyma, confirming the diagnosis of EPN. The patient initially responded well to medical therapy; however, she subsequently developed complications a few days after discharge, ultimately leading to her demise. Emphysematous pyelonephritis is a life‐threatening condition, and sequential microbial (fungal–bacterial) infection underscores its unpredictable clinical course, even after initial improvement. The challenges are further magnified in settings with limited access to advanced diagnostic and interventional resources. Sustained vigilance, along with timely and aggressive multidisciplinary management during the post‐acute phase, remains essential to prevent catastrophic outcomes.

31 January 2026 in Case Reports in Infectious Diseases
Verified
Journal Article
Open access
DMDaniel Pascal Mujuni
Daniel Pascal Mujuni
ASAbid Sadiq
Abid Sadiq
ELElisha Luhwago
Elisha Luhwago
DMDatius Mutalemwa
Datius Mutalemwa
AMAbel Mwanga
Abel Mwanga
KKKajiru G. Kilonzo
Kajiru G. Kilonzo
Malaria‐associated acute kidney injury (MAKI) is a formidable and potentially fatal complication of malaria. Early recognition and timely management can significantly reduce morbidity and mortality, particularly in resource‐limited settings. This case series describes five patients with imported Plasmodium falciparum complicated by MAKI who were treated at Kilimanjaro Christian Medical Center (KCMC) in northeastern Tanzania between December 2023 and January 2024. The cohort comprised of four males and one female, with a mean age of 38.2 ± 18.6 years. All patients presented with a history of fever and a recent history of travel to high‐endemic regions. The mean serum creatinine and urea levels at admission were 736 ± 346.4 μmol/L and 23.1 ± 14.1 mmol/L, respectively. Four patients required hemodialysis, and one experienced malaria recrudescence. Overall survival was 100%. This case series highlights pathophysiological mechanisms, clinical presentations, diagnostic challenges, and management outcomes of MAKI, illustrating its modified natural history. Despite advances in understanding MAKI, early diagnostic and treatment challenges persist. This case series aimed to elucidate the underrecognized burden and patterns of MAKI in a resource‐limited, low‐endemic region within an endemic country.

1 January 2026 in Journal of Diabetes Research
Verified
Journal Article
Open access
RHRaya S. Hamad
Raya S. Hamad
WHWilliam P. Howlett
William P. Howlett
ASAbid Sadiq
Abid Sadiq
ILIsaack A. Lyaruu
Isaack A. Lyaruu
HAHudaa F. Akrabi
Hudaa F. Akrabi
NCNyasatu Chamba
Nyasatu Chamba
Background: Diabetic peripheral neuropathy (DPN) is a common and disabling complication of Type 2 diabetes mellitus (T2DM). Emerging evidence suggests that elevated serum uric acid (SUA) may associate with microvascular complications; however, data from sub‐Saharan Africa remain limited. We examined the association between hyperuricemia and DPN among adults with T2DM in northern Tanzania. Methods: We conducted a hospital‐based cross‐sectional analytical study at a tertiary diabetes clinic from November 2024 to April 2025. Adults aged ≥ 18 years with established T2DM were consecutively recruited. DPN was assessed using the Toronto Clinical Scoring System (TCSS), with DPN defined as TCSS ≥ 6. Fasting SUA was classified as elevated at ≥ 340 μ mol/L in women and ≥ 420 μ mol/L in men. Multivariable logistic regression estimated adjusted odds ratios (aORs). Receiver operating characteristic (ROC) analysis assessed discriminatory performance. Results: Of 321 clinic attendees, 220 participants met eligibility criteria and were analyzed (mean age < 65 years: 69.1%; male: 53.2%). DPN prevalence was 51.8% (114/220). Elevated SUA was present in 52.7% and was strongly associated with DPN (aOR 5.89, 95% CI 3.01–11.51, p < 0.001). Diabetes duration ≥ 5 years (aOR 3.81, p = 0.016), overweight status (aOR 2.18, p = 0.034), elevated fasting glucose (aOR 2.20, p = 0.022), and low HDL (aOR 2.10, p = 0.040) were independently associated with DPN. Elevated total cholesterol was inversely associated (aOR 0.36, p = 0.003). SUA demonstrated moderate discrimination for DPN (AUC 0.773). Conclusions: Hyperuricemia was independently associated with prevalent DPN in this Tanzanian study. SUA may represent a clinically accessible marker for neuropathy risk stratification in resource‐limited settings.

1 January 2026 in Journal of Parasitology Research
Verified
Journal Article
Open access
ESElichilia Shao
Elichilia Shao
Jaffu Othniel ChilongolaJaffu Othniel Chilongola
Jaffu Othniel Chilongola
RBRebecca F. Bodenham
Rebecca F. Bodenham
SCSarah Cleaveland
Sarah Cleaveland
TKTito J. Kibona
Tito J. Kibona
MRMelinda K. Rostal
Melinda K. Rostal
Tick‐borne diseases (TBDs) are significant causes of febrile illnesses in humans. Healthcare workers′ (HCWs) knowledge, attitudes, and practices (KAP) regarding ticks and TBDs may influence prognosis. This study is aimed at assessing the KAP and associated factors among HCWs regarding TBD to provide evidence to improve preventive strategies, diagnosis, and enhance patient outcomes. The electronic questionnaires were used to collect data on respondents′ demographics and KAP on TBD. Of 401 HCWs, the median age was 29 (interquartile range (IR): 26–39). More than half of all HCWs (58.4%) were aged ≤ 30 years, and 51.1% were male. Only 12.2% received training outside Tanzania, 45.4% were medical doctors. Among all HCWs, 47.1% had TBD knowledge above the median. Regarding attitude of HCWs toward TBD, 208 (97.7%) out of 214 who had some awareness of TBD recognized the knowledge gap and a need for further training on TBD. After adjusting for other factors, being male (adjusted odds ratio (AOR) = 1.57, 95% CI: 1.01–2.46), having a postgraduate education (AOR = 3.05, 95% CI: 1.45–6.39), and having received TBD training (AOR = 2.08, 95% CI: 1.28–3.40), remained significantly associated with TBD knowledge above median. Similarly, after adjusting for other factors, being male (AOR = 0.57, 95 % CI = 0.37–0.89), having postgraduate education (including physicians; AOR = 0.28, 95 % CI = 0.13–0.61), and having awareness on TBD were significantly associated with practice above median toward TBD prevention. The knowledge gap on TBD among HCWs was substantial as more than half of the HCWs had knowledge score below median about TBD. On attitude, almost all HCWs who had some awareness of TBD were in need of training on TBD. More than half of HCWs practiced TBD preventative actions below median. Targeted training to improve and expand HCWs′ knowledge, attitudes, and practices regarding TBD are expected to enhance early detection, improve patient outcomes, reduce transmission rates, and strengthen public health response efforts.